QA: Navidea Biopharmaceuticals Inc. in us_medicinal_products/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000810509_2017_Navidea_Biopharmaceuticals_Inc.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000810509')"}

Graph

Absolute values for 0000810509, Navidea Biopharmaceuticals Inc.

  xvar xval
0 LiabilitiesNoncurrent 598,861
1 LiabilitiesCurrent 69,861,788
2 remainder_Liabilities 9,667,240
3 AssetsCurrent 10,826,269
4 AssetsNoncurrent 202,882
5 PropertyPlantAndEquipmentNet 1,251,558
6 Goodwill 180,967
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 24,193,181
11 remainder_Revenues 21,969,706
12 remainder_NetIncome -12,085,556
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 80,127,889
1 Assets 12,461,676
2 Expenses 24,193,181
3 Revenues 21,969,706
4 StockholdersEquity -67,666,213
5 NetIncome -14,309,031
6 ComprehensiveNetIncome -14,309,031
7 BaseVar 75,419,004
8 EconomicCapitalRatio -1.55

Edgar->Model Mapping

Feature Distribution